Article Versions Notes

Bellastella G, Carbone C, Scappaticcio L, Cirillo P, Troiani T, Morgillo F, Vietri MT, Della Corte CM, De Falco V, Napolitano S, et al. Hypothalamic–Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies. Cancers. 2021; 13(16):4036. https://doi.org/10.3390/cancers13164036

Bellastella, Giuseppe, Carla Carbone, Lorenzo Scappaticcio, Paolo Cirillo, Teresa Troiani, Floriana Morgillo, Maria Teresa Vietri, Carminia Maria Della Corte, Vincenzo De Falco, Stefania Napolitano, and et al. 2021. "Hypothalamic–Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies" Cancers 13, no. 16: 4036. https://doi.org/10.3390/cancers13164036

Bellastella, G., Carbone, C., Scappaticcio, L., Cirillo, P., Troiani, T., Morgillo, F., Vietri, M. T., Della Corte, C. M., De Falco, V., Napolitano, S., Maiorino, M. I., De Bellis, A., & Esposito, K. (2021). Hypothalamic–Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies. Cancers, 13(16), 4036. https://doi.org/10.3390/cancers13164036